Lisata Therapeutics Inc. (LSTA) — Cash Flow-to-Debt Ratio
Lisata Therapeutics Inc. (LSTA) has a Cash Flow-to-Debt Ratio of -0.87x as of June 2026, meaning its operating cash flow of $-2.65 Million could theoretically repay -1% of its total liabilities ($3.04 Million) in one year. See financial agility of Lisata Therapeutics Inc. to measure the company's free cash flow as a share of total liabilities.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Lisata Therapeutics Inc. Cash Flow-to-Debt Ratio (1993–2025)
Historical debt coverage capacity for Lisata Therapeutics Inc. across 32 annual periods. For the full cash flow conversion analysis, see Lisata Therapeutics Inc. cash conversion from operations.
Annual Cash Flow-to-Debt Ratio for Lisata Therapeutics Inc. (1993–2025)
Year-by-year debt coverage analysis for Lisata Therapeutics Inc.. Check earnings quality score of Lisata Therapeutics Inc. to evaluate the quality of earnings relative to operating cash generation.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | -5.07x | $-15.95 Million | $3.14 Million | ▼ -49.0% |
| 2024 | -3.40x | $-19.36 Million | $5.68 Million | ▼ -15.6% |
| 2023 | -2.95x | $-20.03 Million | $6.80 Million | ▲ +6.6% |
| 2022 | -3.15x | $-21.17 Million | $6.71 Million | ▲ +29.0% |
| 2021 | -4.44x | $-22.25 Million | $5.01 Million | ▼ -89.3% |
| 2020 | -2.35x | $-8.82 Million | $3.76 Million | ▲ +18.0% |
| 2019 | -2.86x | $-18.88 Million | $6.60 Million | ▼ -2.0% |
| 2018 | -2.80x | $-19.99 Million | $7.13 Million | ▼ -77.2% |
| 2017 | -1.58x | $-20.88 Million | $13.19 Million | ▼ -219.5% |
| 2016 | -0.50x | $-23.67 Million | $47.77 Million | ▲ +57.2% |
| 2015 | -1.16x | $-39.26 Million | $33.92 Million | ▼ -68.3% |
| 2014 | -0.69x | $-46.90 Million | $68.20 Million | ▲ +29.5% |
| 2013 | -0.98x | $-27.10 Million | $27.79 Million | ▼ -52.0% |
| 2012 | -0.64x | $-13.85 Million | $21.59 Million | ▼ -130.6% |
| 2011 | -0.28x | $-20.93 Million | $75.20 Million | ▼ -85.6% |
| 2010 | -0.15x | $-8.48 Million | $56.54 Million | ▲ +19.5% |
| 2009 | -0.19x | $-8.65 Million | $46.45 Million | ▲ +96.2% |
| 2008 | -4.92x | $-4.73 Million | $961.14K | ▲ +63.2% |
| 2007 | -13.36x | $-6.13 Million | $458.95K | ▼ -231.5% |
| 2006 | -4.03x | $-3.64 Million | $902.87K | ▼ -1089.0% |
| 2005 | -0.34x | $-834.00K | $2.46 Million | ▲ +52.8% |
| 2004 | -0.72x | $-1.46 Million | $2.03 Million | ▼ -27.6% |
| 2003 | -0.56x | $-1.02 Million | $1.81 Million | ▼ -212.4% |
| 2002 | 0.50x | $1.01 Million | $2.01 Million | ▲ +296.0% |
| 2001 | -0.26x | $-373.84K | $1.46 Million | ▲ +80.8% |
| 2000 | -1.33x | $-1.98 Million | $1.49 Million | ▼ -355.6% |
| 1999 | -0.29x | $-364.12K | $1.25 Million | ▼ -31.3% |
| 1998 | -0.22x | $-269.60K | $1.21 Million | ▲ +51.3% |
| 1996 | -0.46x | $-304.27K | $666.62K | ▲ +75.2% |
| 1995 | -1.84x | $-838.44K | $455.31K | ▼ -2684.2% |
| 1994 | -0.07x | $-840.00K | $12.70 Million | ▼ -208.4% |
| 1993 | 0.06x | $470.00K | $7.70 Million | — |